133 related articles for article (PubMed ID: 2875953)
1. Expression of Ly-6.2 and Thy-1 antigens on NIH 3T3 cells suppressed after transformation with activated human ras-oncogenes.
Ivanyi D; Janssen JW; Collard JG
Int J Cancer; 1986 Oct; 38(4):575-80. PubMed ID: 2875953
[TBL] [Abstract][Full Text] [Related]
2. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
Sugimoto Y; Ikawa Y; Nakauchi H
Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
4. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
Hollingsworth MA; Rebellato LM; Moore JW; Finn OJ; Metzgar RS
Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
[TBL] [Abstract][Full Text] [Related]
5. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
6. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
Endlich B; Salavati R; Sullivan T; Ling CC
Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
[TBL] [Abstract][Full Text] [Related]
7. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Ly-5 alloantigenic system on epidermal cells.
Leibl H; Hutterer J; Korschan H; Schuler G; Tani M; Tschachler E; Romani N; Wolff K; Stingl G
J Invest Dermatol; 1985 Feb; 84(2):91-5. PubMed ID: 2857189
[TBL] [Abstract][Full Text] [Related]
9. Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations.
Collard JG; van Beek WP; Janssen JW; Schijven JF
Int J Cancer; 1985 Feb; 35(2):207-13. PubMed ID: 3855844
[TBL] [Abstract][Full Text] [Related]
10. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells.
Goyette M; Faris R; Braun L; Hixson D; Fausto N
Cancer Res; 1990 Aug; 50(15):4809-17. PubMed ID: 2196118
[TBL] [Abstract][Full Text] [Related]
12. Effect of ras-activation on the expression of glycosyl-phosphatidylinositol-anchored proteins on the plasma membrane.
Bamezai A; Rock KL
Oncogene; 1991 Aug; 6(8):1445-51. PubMed ID: 1679532
[TBL] [Abstract][Full Text] [Related]
13. Changes in expression of Ia, Thy-1, and Ly-5 antigens in epidermal cells during delayed contact sensitivity reactions in mice: flow cytometric analysis.
Aiba S; Tagami H
J Invest Dermatol; 1986 Feb; 86(2):121-4. PubMed ID: 2875113
[TBL] [Abstract][Full Text] [Related]
14. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
15. Thy-1 inhibits mitogen-induced Ca2+ oscillation in ras-transformed mouse fibroblasts.
Sugimoto Y; Fu T; Hirochika R; Nakauchi H; Ikawa Y; Nozawa Y
Exp Cell Res; 1992 Nov; 203(1):230-5. PubMed ID: 1358665
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene.
Drebin JA; Stern DF; Link VC; Weinberg RA; Greene MI
Nature; 1984 Dec 6-12; 312(5994):545-8. PubMed ID: 6504162
[TBL] [Abstract][Full Text] [Related]
17. Alteration of glycolipids in ras-transfected NIH 3T3 cells.
Matyas GR; Aaronson SA; Brady RO; Fishman PH
Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6065-8. PubMed ID: 3476926
[TBL] [Abstract][Full Text] [Related]
18. Detection of a surface antigen on NIH3T3 cells transfected with a human leukemia oncogene.
Scuderi P; Westin E; Clagett J; Ames R; Gallo R; Blick M; Roth JA
Med Oncol Tumor Pharmacother; 1985; 2(4):233-42. PubMed ID: 3910974
[TBL] [Abstract][Full Text] [Related]
19. Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.
Stevenson M; Volsky DJ
Mol Cell Biol; 1986 Oct; 6(10):3410-7. PubMed ID: 3025592
[TBL] [Abstract][Full Text] [Related]
20. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
